{"id":"https://openalex.org/W2484444366","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-088","title":"Abstract LB-088: Heterodimeric IL-15 enhances tumor infiltration, persistence and effector functions of adoptively transferred tumor-specific T cells in the absence of lymphodepletion","display_name":"Abstract LB-088: Heterodimeric IL-15 enhances tumor infiltration, persistence and effector functions of adoptively transferred tumor-specific T cells in the absence of lymphodepletion","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2484444366","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-088","mag":"2484444366"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-lb-088","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-088","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-lb-088","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111656805","display_name":"Sinnie Sin Man Ng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sinnie Ng","raw_affiliation_strings":["1National Cancer Institute at Frederick, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute at Frederick, Frederick, MD;","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013651491","display_name":"Cristina Bergamaschi","orcid":"https://orcid.org/0000-0003-1030-2662","observed_orcids":["https://orcid.org/0000-0003-1030-2662"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Bergamaschi","raw_affiliation_strings":["1National Cancer Institute at Frederick, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute at Frederick, Frederick, MD;","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034466658","display_name":"Bethany A. Nagy","orcid":"https://orcid.org/0000-0001-7454-9344","observed_orcids":["https://orcid.org/0000-0001-7454-9344"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bethany Nagy","raw_affiliation_strings":["1National Cancer Institute at Frederick, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute at Frederick, Frederick, MD;","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078755426","display_name":"Candido Alicea","orcid":"https://orcid.org/0000-0003-4434-6858","observed_orcids":["https://orcid.org/0000-0003-4434-6858"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Candido Alicea","raw_affiliation_strings":["1National Cancer Institute at Frederick, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute at Frederick, Frederick, MD;","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048845755","display_name":"Shawn M. Jensen","orcid":"https://orcid.org/0000-0002-4843-5930","observed_orcids":["https://orcid.org/0000-0002-4843-5930"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn M. Jensen","raw_affiliation_strings":["2Earle A Chiles Research Institute, Portland Providence Medical Center, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Earle A Chiles Research Institute, Portland Providence Medical Center, Portland, OR","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067266240","display_name":"Bernard A. Fox","orcid":"https://orcid.org/0000-0002-4452-5947","observed_orcids":["https://orcid.org/0000-0002-4452-5947"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bernard A. Fox","raw_affiliation_strings":["2Earle A Chiles Research Institute, Portland Providence Medical Center, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Earle A Chiles Research Institute, Portland Providence Medical Center, Portland, OR","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069687616","display_name":"Barbara K. Felber","orcid":"https://orcid.org/0000-0001-8925-8128","observed_orcids":["https://orcid.org/0000-0001-8925-8128"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara K. Felber","raw_affiliation_strings":["1National Cancer Institute at Frederick, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute at Frederick, Frederick, MD;","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066261446","display_name":"George N. Pavlakis","orcid":"https://orcid.org/0000-0002-4027-4036","observed_orcids":["https://orcid.org/0000-0002-4027-4036"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George N. Pavlakis","raw_affiliation_strings":["1National Cancer Institute at Frederick, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute at Frederick, Frederick, MD;","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"LB","last_page":"088"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.39500001072883606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.39500001072883606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.2538999915122986,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.17409999668598175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.8840000033378601},{"id":"https://openalex.org/keywords/adoptive-cell-transfer","display_name":"adoptive cell transfer","score":0.8920000195503235},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.9049999713897705},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.8389999866485596},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6600000262260437},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8109999895095825},{"id":"https://openalex.org/keywords/t-cell-persistence","display_name":"T cell persistence","score":0.5509999990463257},{"id":"https://openalex.org/keywords/tumor-infiltration","display_name":"tumor infiltration","score":0.46299999952316284},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/homeostatic-cytokines","display_name":"homeostatic cytokines","score":0.6990000009536743},{"id":"https://openalex.org/keywords/cytotoxic-function","display_name":"cytotoxic function","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.598652720451355},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.583777904510498},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5717883110046387},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5384722948074341},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5381084680557251},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5248275399208069},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4527982175350189},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4342508912086487},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.43143588304519653},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2800372242927551},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.24581196904182434},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11806723475456238},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-lb-088","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-088","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-lb-088","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2565855748","https://openalex.org/W2796602225","https://openalex.org/W2073281781","https://openalex.org/W2522876697","https://openalex.org/W1970530486","https://openalex.org/W2109663508","https://openalex.org/W2158187351","https://openalex.org/W2036487118","https://openalex.org/W2259088148","https://openalex.org/W2135124419"],"abstract_inverted_index":{"Abstract":[0],"Adoptive":[1],"cell":[2],"transfer":[3],"(ACT)":[4],"is":[5,16],"a":[6,74,214],"promising":[7],"immunotherapeutic":[8],"approach":[9],"for":[10,219,276],"cancer.":[11],"Lymphodepletion":[12,30],"of":[13,35,46,62,77,96,103,120,180,189,206,253,262,267,272],"the":[14,47,52,60,78,82,94,97,132,169,204,260,268,273],"host":[15],"associated":[17],"with":[18,81,157],"favorable":[19],"ACT":[20,58,207],"outcomes":[21],"but":[22,146],"it":[23],"may":[24],"cause":[25],"detrimental":[26],"effects":[27,95],"in":[28,32,59,71,101,131,152,168,193,208,259],"humans.":[29],"results":[31],"high":[33],"level":[34,188],"homeostatic":[36],"cytokines":[37],"including":[38],"Interleukin-15":[39],"(IL-15)":[40],"that":[41,54,68,162],"support":[42],"survival":[43,198],"and":[44,118,126,177,191,197,211,250],"proliferation":[45,176],"transferred":[48,123,255],"lymphocytes.":[49],"We":[50,64,91],"tested":[51],"hypothesis":[53],"exogenous":[55],"IL-15":[56,70,79,83,89,245],"enhances":[57,246],"absence":[61,102,261],"lymphodepletion.":[63,263],"have":[65],"previously":[66],"shown":[67],"bioactive":[69],"vivo":[72],"comprises":[73],"stable":[75],"complex":[76],"chain":[80],"Receptor":[84],"alpha":[85],"chain,":[86],"termed":[87],"heterodimeric":[88],"(hetIL-15).":[90],"therefore":[92],"evaluated":[93],"combination":[98],"regimen":[99],"ACT+hetIL-15":[100],"lymphodepletion":[104,135],"by":[105,136],"transferring":[106],"melanoma-specific":[107],"Pmel-1":[108,124,138,166,182],"T":[109,129,257],"cells":[110,125,130,139,167,258],"into":[111],"B16":[112],"melanoma-bearing":[113],"mice.":[114],"hetIL-15":[115,163,172,201],"promoted":[116],"infiltration":[117],"persistence":[119,148,249],"both":[121],"adoptively":[122,254],"endogenous":[127],"CD8+":[128],"tumor.":[133],"Following":[134],"irradiation,":[137],"also":[140,174],"localized":[141],"to":[142,154,217],"tumor":[143,170,195,247],"sites":[144],"efficiently,":[145],"their":[147,186],"was":[149],"severely":[150],"reduced":[151],"comparison":[153],"mice":[155],"treated":[156],"hetIL-15.":[158],"Importantly,":[159],"we":[160],"found":[161],"preferentially":[164],"enriched":[165],"sites.":[171],"treatment":[173],"supported":[175],"cytotoxic":[178],"function":[179],"tumor-infiltrating":[181],"cells,":[183],"while":[184],"reducing":[185],"expression":[187],"PD-1,":[190],"resulted":[192],"improved":[194],"control":[196],"benefit.":[199],"Thus,":[200],"administration":[202],"improves":[203],"outcome":[205],"non-lymphodepleted":[209],"hosts,":[210],"can":[212],"be":[213],"valuable":[215],"addition":[216],"strategies":[218],"cancer":[220],"immunotherapy.":[221],"Citation":[222],"Format:":[223],"Sinnie":[224],"Ng,":[225],"Cristina":[226],"Bergamaschi,":[227],"Bethany":[228],"Nagy,":[229],"Candido":[230],"Alicea,":[231],"Shawn":[232],"M.":[233],"Jensen,":[234],"Bernard":[235],"A.":[236],"Fox,":[237],"Barbara":[238],"K.":[239],"Felber,":[240],"George":[241],"N.":[242],"Pavlakis.":[243],"Heterodimeric":[244],"infiltration,":[248],"effector":[251],"functions":[252],"tumor-specific":[256],"[abstract].":[264],"In:":[265],"Proceedings":[266],"107th":[269],"Annual":[270],"Meeting":[271],"American":[274],"Association":[275],"Cancer":[277,288],"Research;":[278],"2016":[279],"Apr":[280],"16-20;":[281],"New":[282],"Orleans,":[283],"LA.":[284],"Philadelphia":[285],"(PA):":[286],"AACR;":[287],"Res":[289],"2016;76(14":[290],"Suppl):Abstract":[291],"nr":[292],"LB-088.":[293]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-08-23T00:00:00"}